Aethlon Medical (AEMD) Net Cash Flow Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.72% |
| Sep 30, 2025 | 44.61% |
| Jun 30, 2025 | -17.93% |
| Mar 31, 2025 | -34.11% |
| Dec 31, 2024 | -9.37% |
| Sep 30, 2024 | 26.93% |
| Jun 30, 2024 | 36.39% |
| Mar 31, 2024 | -20.45% |
| Dec 31, 2023 | -54.17% |
| Sep 30, 2023 | -21.11% |
| Jun 30, 2023 | -13.95% |
| Mar 31, 2023 | -33.06% |
| Dec 31, 2022 | -19.61% |
| Sep 30, 2022 | 51.18% |
| Jun 30, 2022 | -11.78% |
| Mar 31, 2022 | -40.97% |
| Dec 31, 2021 | -109.76% |
| Sep 30, 2021 | -21.41% |
| Jun 30, 2021 | 82.88% |
| Mar 31, 2021 | -15.03% |
| Dec 31, 2020 | -19.08% |
| Sep 30, 2020 | 2.82% |
| Jun 30, 2020 | 4.99% |
| Mar 31, 2020 | 37.35% |
| Dec 31, 2019 | 7.79% |
| Sep 30, 2019 | -43.43% |
| Jun 30, 2019 | -24.70% |
| Mar 31, 2019 | -10.52% |
| Dec 31, 2018 | -16.41% |
| Sep 30, 2018 | -114.68% |
| Jun 30, 2018 | -55.50% |
| Mar 31, 2018 | 139.49% |
| Dec 31, 2017 | 98.27% |
| Sep 30, 2017 | 30.80% |
| Jun 30, 2017 | -36.43% |
| Mar 31, 2017 | 45.02% |
| Dec 31, 2016 | -25.23% |
| Sep 30, 2016 | -90.28% |
| Jun 30, 2016 | -225.02% |
| Mar 31, 2016 | -38.83% |
| Dec 31, 2015 | -30.60% |
| Sep 30, 2015 | -40.14% |
| Jun 30, 2015 | 305.94% |